About Acarix

Dr. Werner Braun


Born: 1946.

Education: Dr. Werner Braun holds a PhD in physics from the Technical University of Munich, Germany.

Previous engagements/experience: Dr. Werner Braun has international experience
from leading positions in medtech companies in Germany, Austria and the US and
has been CEO of BIOTRONIK SE & Co and an external Board member of Technologies
Ltd. Chilworth.

Other significant ongoing assignments: Chairman of the Board of Miracor S.A and CEO of WEMANITEC GmbH.

Acarix holdings: 34,000 shares and 20,000 warrants.

Anders Jacobson

Board member since 2020

Born: 1967.

Education: Anders Jacobson holds an MSc in engineering physics from Uppsala University, Sweden.

Previous engagements/experience: Anders Jacobson has held various senior positions in different life science companies, including Biotage and St. Jude Medical, and within the technical consulting industry, including Sigma, Teleca and Prevas. In his previous positions, Anders has worked in research and development, manufacturing, service and technical sales in a global environment.

Other significant ongoing assignments: Board member of Acarix A/S and CTO of Senzime AB.

Acarix holdings: No shares or warrants.

Paolo Raffaelli


Born: 1965.

Education: Paolo Raffaelli holds an MSc in electronics from University La Sapienza Rome, Italy, and an MBA from IMD Business School in Lausanne, Switzerland. He also completed a number of traineeships at UCLA, Kellogg Business School.

Previous engagements/experience: Paolo Raffaelli has over 20 years of international management experience in sales, marketing and business management in the cardiovascular field. He has experience of managing suppliers and diversified sales channels in medical technology, including up and downstream strategic marketing. His previous positions include Global Marketing VP at Maquet Critical Care and Marketing and Education Director EMEA at Abbott. Before that, Paolo spent more than 12 years at Medtronic in such positions as Chairman of the Board and CEO.

Other significant ongoing assignments: None.

Acarix holdings: No shares or warrants.